Should You Buy Clorox Stock At This Price?
Today’s big story: Could Anthropic Stock Fall 25%?
Clorox (CLX) stock trades at 19.5 times earnings, against 21.5 for the median S&P 500 company. That discount has held even after the shares returned 25.7% from October 20 to November 18, while the S&P 500 lost 5.0%. Priced below the broader market, the maker of Glad Trash and Brita can look like a gift. It can also be a fair price for a business whose margins have slipped. So what does a buyer actually get for that lower multiple?

What Clorox Buyers Get At This Price
A buyer gets a business whose sales are growing again, though from a weak year. Clorox’s revenue reached $7.2 billion over the twelve months to September 2026, up 6.3% from a year earlier, and its largest segment, Health and Wellness, sold $2.7 billion in fiscal 2026. Yet investors pay $1.80 for each dollar of Clorox’s sales, against $3.10 for the S&P 500 as a whole.
The shares also yield 4.6% in dividends at the November 18 close. For an income buyer, that yield is the heart of the value case. But as shown below, Clorox’s free cash flow did not cover its dividend over the past year.
Clorox’s 4.6% yield rests on a business whose gross margin has slipped. If that income has to last you for years, one company’s margins should not carry all of it. Meanwhile, the Trefis Income Solution pays a dividend yield about 3x the S&P 500’s, from 50 stocks with at least 10 straight years of dividends. See what it pays.
Clorox’s Gross Margin Has Slipped
Over the twelve months to September 2026, Clorox kept 41.9% of its sales as gross profit. Across the last three such twelve-month periods, that margin averaged 43.6%. Sales tell the opposite story: the latest growth is well above the 1.0% average across those three periods. That growth follows a 9.3% fall in revenue in the twelve months before, so Clorox is winning back lost ground. The gain came in one quarter: revenue rose 33.3% in fiscal Q1 2027, after an 18.9% fall a year earlier. The three quarters before it were flat or lower. For fiscal 2027, Clorox expects organic sales growth of flat to plus 1% once the lift from lapping its ERP systems changeover is taken out.
Profit has weakened along with the margin. Net income fell to $677 million over the latest twelve months, from $791 million a year earlier. So the earnings behind Clorox’s lower multiple are shrinking, not growing.
Cash is the larger risk for a holder. Clorox generated $453 million of free cash flow over the twelve months to September 2026, which was less than the $602 million it paid in dividends. Its total debt stood at $5.59 billion at the end of September, against $3.08 billion a year earlier.
How Clorox Plans To Win Back Its Margin
Clorox is raising prices. Management said on the fiscal Q1 2027 call, held November 2, that the company faces continued input cost pressures. Clorox has already put targeted pricing in place across all four of its reporting segments. Glad Trash, which depends heavily on resin, got a high single-digit price increase in July. The company is working on more pricing for the back half of the fiscal year, though it says such moves take a while to show up in margins.
The company’s own bar is lower for now. In its November 2 release, Clorox lowered its fiscal 2027 gross margin guide to 41.5%, from a previous guide of 42.0% in August. Clorox guides fiscal 2027 diluted earnings of $5.41 to $5.71 a share, with the $5.56 midpoint unchanged from its August guide.
At $108.39 a share, buying Clorox is mainly a bet that its price increases restore the gross margin. It is less a bet that the market has misjudged a sound business. On October 29, Clorox named Fabian Garcia as its new chief executive, starting January 5, 2027. Clorox is expected to report in February 2027. That report will show how its fiscal Q2 2027 gross margin compares with the full-year guide.
Reading a discount against the margin behind it is how we approach value stocks, and we are always glad to hear of a sharper method.
Found A Better Strategy? We’d Love To Learn.
Ours is the Trefis High Quality (HQ) Portfolio: 30 quality stocks in equal weight. Since its September 2020 launch it has returned more than 105%, ahead of a benchmark that combines the S&P 500, S&P MidCap and Russell 2000. If yours has done better, tell us about it. If not, come take a look.
Spot an error or want more like this? Tell us in 10 seconds.